Lupin gets tentative approval from USFDA for Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush
Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
Dr. Singh proposes upskilling medicos with AI, Quantum and other newer technologies to meet the changing requirements of patient care
Lokavant provides clinical trial intelligence
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
Subscribe To Our Newsletter & Stay Updated